Combining its expertise in agriculture, medicine and technology, Israel is positioned to become the world’s largest provider in the relatively new field of medicinal marijuana. Currently, there are 120 government-approved studies on the effectiveness of medical-grade cannabis underway in Israel. Clinical trials are being used to test the capabilities of marijuana for treatment of diseases such as autism, epilepsy, psoriasis and tinnitus. Experts estimate that the sale of medical marijuana will exceed $50 billion a year by 2025. Yuval Landschaft, head of the Health Ministry’s medical cannabis unit, told Reuters, “In the United States they use recreational marijuana for medical use — that’s like making chicken soup when you have a cold. We’re the ones making the antibiotics.”
The Israeli strategy is to manufacture and distribute medical-grade cannabis produced under stringent government and clinically-proven quality controls. Unlike the US, today’s largest producer of medical marijuana, Israeli government authorities are far more liberal in supporting cannabis research...
Become a Member
-
Read all member content
Get exclusive in-depth reports from Israel.
-
Get exclusive in-depth reports from Israel
Connect with Israel, right from your home.
-
Lift up the voice of truth and hope
Support Jerusalem-based Zionist journalism.
Already a member? Login here.
